Thrivent Financial for Lutherans’s Galectin Therapeutics GALT Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-13,727	Closed	-$57K	–	2220
2019 Q2	$57K	Sell	13,727 -1,451	-10%	-$6.03K	﹤0.01%	2176
2019 Q1	$78K	Buy	+15,178	New	+$78K	﹤0.01%	2142
2017 Q4	–	Sell	-6,000	Closed	-$13K	–	2126
2017 Q3	$13K	Buy	+6,000	New	+$13K	﹤0.01%	2120